Vaxart Inc. (VXRT) Amount of Cash per Share

Corporate emblem and logo of Vaxart Inc. (VXRT)

Geopolitical tensions and pandemic threats are driving government orders for Vaxart, Inc. (VXRT). The company develops tablet-based vaccines that optimize international delivery by eliminating the cold chain, thereby increasing margins. This chart of cash per share confirms the current financial status, where 0.00 shows the value of this parameter. However, reliance on US grants and the risk of failed trials create vulnerability during cash shortages.

VXRT: vaxart.com Cash per Single Share 07/04/2022 - 07/19/2025

Analytical breakdowns for Vaxart, Inc.

- price and consensus price forecast:
- cash position and cash flow details:
Summary company analysis:VXRT Vaxart Corp
Manufactured product of vaxart.com

Developing oral vaccines requires significant capital expenditures prior to market entry. Analyzing the cash per share chart, an investor can see the ratio of total liquidity to the number of common shares. This indicator determines the actual financial cushion per unit of equity. For Vaxart, Inc. (VXRT), which lacks commercial sales, this metric measures the burn rate. It demonstrates the company's ability to fund clinical trials without resorting to emergency equity offerings.